LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - UroGen Pharma (NASDAQ: URGN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ URGN UroGen Pharma
Schoenberg Mark / officer: Chief Medical Officer
06/09/2025
Sell
$7.37
5,162
$38K
153,378